MoonLake Immunotherapeutics

Q3 2025 13F Holders

Symbol
MLTX
CUSIP
61559X104
Type
Equity
Class
CLASS A ORD
Num filings
174
Total reported value, excl. options
$270 M
Manager Report Date Value ($000) Shares Option Type